Health Catalyst's (NASDAQ: HCAT) third quarter financial results release is scheduled for Wednesday 6th November 2024, before the market opens. Investors and analysts will be able to assess the company's performance during the quarter.
According to the predictions of financial experts on Wall Street, the concern is expected to announce an anticipated $0.10 profit per share for the quarter. Further, the firm is poised to disclose a total revenue of $76.3 million for the period.
Wall Street analysts have shared their forecasts for the company's annual performance, predicting a total revenue of $307.49 million. Additionally, they expect the company to post profit of $0.36 per share for the fiscal year.
During the same quarter of the previous year, the company made public its income of $0.03 per share, which were derived from a quarterly revenue of $73.77 million.
Additionally, The company will host a conference call with investors and analysts on 6th November 2024 at 04:30 PM eastern time to review the Q3 2024 financial results.
Health Catalyst (HCAT) closed Friday's regular trading session at $7.70, showing a 0.9 percent decrease, with a volume of 376.70 thousand shares.
